Private company

BioClinica

BioClinica is an American pharmaceutical company based in Philadelphia, incorporated in Delaware.¹

Last updated Oct 21, 2026.

Overview

Jan 1, 1998Founded¹

Industrypharmaceutical industry¹
HeadquartersPhiladelphia¹
Websitewww.bioclinica.com
Incorporated inDE³
Business address826 Newtown-Yardley Road, Newtown, Pa 18940-1721³

See how the biggest companies compare on our leaderboards

What it owns

What BioClinica reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, before depreciation	$48.3M⁴ Dec 31, 2012	$38.0M⁴ Dec 31, 2011	+26.9%
Accumulated depreciation	$26.8M⁴ Dec 31, 2012	$21.8M⁴ Dec 31, 2011	+22.7%
Property and equipment, net	$21.5M⁴ Dec 31, 2012	$16.2M⁴ Dec 31, 2011	+32.6%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$13.9M⁴ Dec 31, 2012	$12.6M⁴ Dec 31, 2011	+10.7%

Intangibles and goodwill

Item	Latest	A year before	Change
Goodwill	$34.3M⁴ Dec 31, 2012	$34.3M⁴ Dec 31, 2011	0%
Intangible assets, net (excluding goodwill)	$1.3M⁴ Dec 31, 2012	$1.8M⁴ Dec 31, 2011	−29.5%
Finite-lived intangibles, gross	$4.4M⁴ Dec 31, 2012	$4.4M⁴ Dec 31, 2011	0%
Accumulated amortization	$3.1M⁴ Dec 31, 2012	$2.5M⁴ Dec 31, 2011	+21.0%
Finite-lived intangibles, net	$1.3M⁴ Dec 31, 2012

Leadership

Who has led BioClinica, and when. Pick a name to see everywhere that person has worked.

200020052010201520202025

Chief executive officerMark L. Weinstein Jan 3, 2006 to Mar 14, 2013⁵
PresidentMark L. Weinstein Jan 3, 2006 to Mar 14, 2013⁵
Chief financial officerTed Kaminer Mar 3, 2006 to Mar 14, 2013⁶

Board members and other officers (13)

EVP and CTOGarry D. Johnson Feb 29, 2012 to Mar 14, 2013⁷
Senior VP/Business DevelopmentColin Miller Mar 3, 2006 to Mar 2, 2009⁸
Vice President of OperationsDavid Pitler Mar 3, 2006 to Feb 22, 2011⁹
Board memberJohn P. Repko May 13, 2011 to Mar 14, 2013¹⁰
Board memberMarcella Locastro May 13, 2011 to Mar 14, 2013¹¹
Board memberJames W. Lovett Oct 12, 2010 to Oct 12, 2010¹²
Board memberWallace P. Parker Jr. Nov 19, 2010 to Mar 14, 2013¹³
Board memberAdeoye Y. Olukotun Aug 27, 2008 to Mar 14, 2013¹⁴
Board memberMark L. Weinstein Jan 3, 2006 to Mar 14, 2013⁵
Board memberE. Martin Davidoff Mar 16, 2006 to Mar 14, 2013¹⁵
Board memberDavid E. Nowicki May 12, 2006 to Mar 14, 2013¹⁶
Board memberDavid M. Stack May 12, 2006 to Nov 19, 2010¹⁷
Board memberPaula B. Stafford May 12, 2006 to Jun 4, 2008¹⁸

Former names

BIO IMAGING TECHNOLOGIES INCDec 18, 1996 to Jul 9, 2009³

Timeline

Jan 3, 2006New chief executive Mark L. Weinstein becomes CEO⁵
Jan 1, 1998Founded Founded¹

SEC filer profile

How BioClinica is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARBIOCLINICA INC²
CIK0000822418
Employer ID (EIN)11-2872047²
Incorporated inDelaware²
Fiscal year endsDecember 31²
Industry code (SIC)8734 Services-Testing Laboratories²
Business address826 Newtown-Yardley Road, Newtown, PA 18940-1721²
Phone2677573000²
Shares outstanding15,685,671 as of Jan 31, 2013⁴
Public float$60.7M as of Jun 30, 2012⁴
On EDGAR sinceJul 31, 1996²
Filings682 in all: 4 (329), 8-K (86), SC 13G/A (31), 10QSB (26), 10-Q (24), SC 13G (22), DEF 14A (16), SC 13D/A (12)²
All 47 form types
3 (11), ARS (11), 10KSB (9), 10-K (8), S-8 POS (8), SC TO-C (7), 4/A (6), S-8 (6), 5 (5), 8-K/A (5), EFFECT (5), SC 13D (5), POS AM (4), UPLOAD (4), 8-A12B (3), CORRESP (3), PRE 14A (3), S-3 (3), S-3/A (3), SC 14D9/A (3), SC14D9C (3), 8-A12B/A (2), DEFA14A (2), SC TO-T/A (2), 10-K/A (1), 10QSB/A (1), 15-12G (1), 25-NSE (1), 424B3 (1), 5/A (1), 8-A12G (1), CERTAMX (1), CT ORDER (1), DEFC14A (1), DFAN14A (1), DFRN14A (1), PREM14A (1), SC 14D9 (1), SC TO-T (1)
Latest filingsAnnual report (10-K) Feb 22, 2013
Quarterly report (10-Q) Nov 9, 2012
Proxy statement (DEF 14A) Apr 9, 2012
Latest 8-K (8-K) Mar 14, 2013

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataBioClinica on Wikidata
2
SEC EDGARBioClinica filings on SEC EDGAR
3
SEC EDGARBioClinica filings on SEC EDGAR
4
SEC EDGARBioClinica 10-K for fiscal 2012
5
SEC EDGARMark L. Weinstein, Chief executive officer
6
SEC EDGARTed Kaminer, Chief financial officer
7
SEC EDGARGarry D. Johnson, EVP and CTO
8
SEC EDGARColin Miller, Senior VP/Business Development
9
SEC EDGARDavid Pitler, Vice President of Operations
10
SEC EDGARJohn P. Repko, Board member
11
SEC EDGARMarcella Locastro, Board member
12
SEC EDGARJames W. Lovett, Board member
13
SEC EDGARWallace P. Parker Jr., Board member
14
SEC EDGARAdeoye Y. Olukotun, Board member
15
SEC EDGARE. Martin Davidoff, Board member
16
SEC EDGARDavid E. Nowicki, Board member
17
SEC EDGARDavid M. Stack, Board member
18
SEC EDGARPaula B. Stafford, Board member